NCT03652428View on ClinicalTrials.gov

Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 2, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Locally Advanced Pancreatic Cancer
Interventions
DRUG

Gemcitabine

see arm description

RADIATION

Hypofractionated Ablative Proton Therapy

see arm description

Trial Locations (2)

20007

RECRUITING

MedStar Georgetown University Hospital, Washington D.C.

21201

RECRUITING

University of Maryland Medical Center/Maryland Proton Treatment Center, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER